Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy.
Baxevanis
C N
CN
Department of Immunology, Hellenic Anticancer Institute, Athens, Greece.
Papamichail
M
M
D000951:Antigens, Neoplasm / Q000276:immunology; D016207:Cytokines / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014612:Vaccines / Q000276:immunology
D000951:Antigens, Neoplasm; D016207:Cytokines; D007376:Interleukin-2; D014612:Vaccines